Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avadel Pharmaceuticals PLC

AVDL
Current price
17.33 USD +0.08 USD (+0.46%)
Last closed 17.38 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 456 478 208 USD
Yield for 12 month +75.40 %
1Y
3Y
5Y
10Y
15Y
AVDL
21.11.2021 - 28.11.2021

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, 2

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

22.9 USD

P/E ratio

Dividend Yield

Current Year

+27 963 000 USD

Last Year

+1 496 000 USD

Current Quarter

+19 453 000 USD

Last Quarter

+7 014 000 USD

Current Year

+25 351 000 USD

Last Year

-1 493 000 USD

Current Quarter

+18 760 000 USD

Last Quarter

+6 897 000 USD

Key Figures AVDL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -136 083 008 USD
Operating Margin TTM -128 %
PE Ratio
Return On Assets TTM -57.92 %
PEG Ratio 0.07
Return On Equity TTM -481.35 %
Wall Street Target Price 22.9 USD
Revenue TTM 27 963 000 USD
Book Value 0.98 USD
Revenue Per Share TTM 0.35 USD
Dividend Share
Quarterly Revenue Growth YOY -100 %
Dividend Yield
Gross Profit TTM 16 592 000 USD
Earnings Share -2 USD
Diluted Eps TTM -2 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AVDL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AVDL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AVDL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 48.1311
Price Sales TTM 51.7944
Enterprise Value EBITDA -9.0253
Price Book MRQ 16.517

Financials AVDL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AVDL

For 52 weeks

9.5 USD 18.01 USD
50 Day MA 15.29 USD
Shares Short Prior Month 10 474 142
200 Day MA 13.51 USD
Short Ratio 6.47
Shares Short 10 394 704
Short Percent 11.57 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

399.12 USD Microsoft Corporation -4.91 (-1.22%)
Detailed analytics

ETF funds


M

MDAXEX

207.85 CHF iShares MDAX UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2175.88 USD Gold +5.94 (+0.27%)
Detailed analytics